𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of Ursodeoxycholic Acid on Biliary Bile Acid and Bile Lipid Composition in Gallstone Patients

✍ Scribed by Adolf Stiehl; Richard Raedsch; Gerda Rudolph; Siegfried Walker


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
546 KB
Volume
4
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


In five patients with radiolucent gallstones, the effect of ursodeoxycholic acid (Urso) in doses of 250,500, 750, 1,000, and 1,250 mg per day on biliary lipid and bile acid composition was studied. Biliary cholesterol decreased from 8.8 f 0.8 mole% to 4.4 f 0.2 mole% at 500 mg Urso per day (7.1 mg per kg) and to 4.2 2 0.3 mole% at 750 mg Urso per day (10.7 mg per kg). Administration of 1,000 or 1,250 mg Urso per day produced no further decrease of biliary cholesterol. The biliary content of phospholipids and total bile acids remained unchanged.

During Urso treatment, the relative amounts of glyco-Urso and tauro-Urso in bile increased. Glyco-Urso reached a plateau at 49.1 2 2.1% of total bile acids during treatment with 1,000 mg Urso per day, and tauro-Urso increased up to 4.3 2 1.5% of total bile acids at 250 mg Urso per day. Simultaneously cholic acid, chenodeoxycholic acid, deoxycholic acid, and lithocholic acid decreased.

The data indicate that Urso treatment reduces biliary cholesterol efficiently already at a dose of 500 mg per day; biliary bile acid composition changes up to 1,000 mg Urso per day. Doses greater than 1,000 mg per day produced no additional alterations in bile composition.


πŸ“œ SIMILAR VOLUMES


Biliary bile acids in primary biliary ci
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Santiago Munoz; Guada πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed

Effect of ursodeoxycholic acid on bile a
✍ Dr. Ashok K. Batta; Gerald Salen; Renu Arora; Sarah Shefer; G. Stephen Tint; Joh πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 571 KB

We have compared the effect of ursodeoxycholic acid with placebo on the clinical state, blood liver chemistries and serum and urinary bile acids in four patients with primary biliary cirrhosis. All parameters were evaluated monthly, and bile acid composition was measured by capillary gas-liquid chro

Changes in bile acid composition in pati
✍ Andrea Crosignani; Mauro Podda; Pier Maria Battezzati; Emanuela Bertolini; Massi πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 855 KB

We describe a detailed study of the effects of ursodeoxycholic acid administration on bile acid composition of the serum and bile of patients with primary biliary cirrhosis. Gas chromatography-mass spectrometry was used to analyze bile acids from 10 patients with primary biliary cirrhosis before and

Mesophase formation during cholesterol g
✍ C. C. Su; W. I. Higuchi; I. T. Gilmore; R. G. Danzinger; A. F. Hofmann πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 235 KB

Duodenal bile obtained from patients with gallstones who were acutely infused with chenodeoxycholic acid, ursodeoxycholic acid, or cholic acid were examined for the propensity toward the formation of a liquid crystalline mesomorphic phase when cholesterol gallstones were incubated in these bile acid